Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review

International Journal of Cancer

Volumn 139, Issue 3, 2016, Pages 554-573

  Segnan, Nereo ^a   Minozzi, Silvia ^a   Armaroli, Paola ^a   Cinquini, Michela ^a   Bellisario, Cristina ^a   González Lorenzo, Marien ^a   Gianola, Silvia ^a   Ponti, Antonio ^a  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

breast cancer; natural history; overdiagnosis

Indexed keywords

AGE DISTRIBUTION; AUTOPSY; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL FEATURE; COHORT ANALYSIS; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; OCCULT CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT REFUSAL; BREAST NEOPLASMS; CANCER STAGING; DISEASE COURSE; FEMALE; META ANALYSIS; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS; TUMOR REGRESSION;

AUTOPSY; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM STAGING; PATIENT OUTCOME ASSESSMENT; PREVALENCE; SURVIVAL ANALYSIS;

EID: 84963579515     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30105     Document Type: Review

References (52)

1. Everson TC, Cole WH., Spontaneous Regression of Cancered. Philadelphia, Pa: W.B. Saunders, 1966.
2. Zahl PH, Gotzsche PC, Maehlen J., Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 2011; 12: 1118-24.
3. Welch HG, Black WC., Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13.
4. Esserman LJ, Thompson IM, Jr., Reid B., Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013; 310: 797-8.
5. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.
6. Johnstone PA, Norton MS, Riffenburgh RH., Survival of patients with untreated breast cancer. J Surg Oncol 2000; 73: 273-7.
7. Papac RJ., Spontaneous regression of cancer: possible mechanisms. In Vivo 1998; 12: 571-8.
8. Liberati A, Altman DG, Tetzlaff J, et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100
9. Wells GA, Shea B, O'Connell D, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm, 2010.
10. Quality assessment for Case series. Available at: http://www.nice.org.uk/guidance/cg3/resources/appendix-4-quality-of-case-series-form2.
11. Atkin GK, Scott MA, Wiggins JE, et al., The incidence, indications and outcome for the non-operative management of breast cancer. J Surg Oncol 2007; 96: 137-43.
12. Betsill WL, Jr., Rosen PP, Lieberman PH, et al., Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. Jama 1978; 239: 1863-7.
13. Bloom HJ, Richardson WW, Harries EJ., Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy. Br Med J 1962; 2: 213-21.
14. Bouchardy C, Rapiti E, Fioretta G, et al., Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-7.
15. Chang EY, Glissmeyer M, Tonnes S, et al., Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg 2006; 192: 471-3.
16. Christensen LH, Andersson M, Storm HH., [Untreated breast cancer in Denmark 1978-1995]. Ugeskr Laeger 2001; 163: 2774-8.
17. Daland EM., Untreated cancer of the breast. Surg Gynecol Obstet 1927; 44: 264-8.
18. Eusebi V, Feudale E, Foschini MP, et al., Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223-35.
19. Forber JE., Incurable cancer: an investigation of hospital patients in eastern London. Rep Public Health Med Subj 1931; 66: 1-59.
20. Greenwood M., A report on the natural duration of cancer. Rep Public Health Med Subj 1926; 33: 1-26.
21. Joseph K, Vrouwe S, Kamruzzaman A, et al., Outcome analysis of breast cancer patients who declined evidence-based treatment. World J Surg Oncol 2012; 10.
22. Kolodziejska H, Korzeniowski S, Kurzawinska B, et al., Studies on the survival of treated and untreated patients with advanced breast cancer. Nowotwory 1971; 21: 173-6.
23. Lazarus-Barlow WS, Leeming JH., The natural duration of cancer. Br Med J 1924; 2: 266-7.
24. Nathanson IT, Welch CE., Life expectancy and incidence of malignant disease: carcinoma of the breast. Am J Cancer 1936; 28: 40-53.
25. Page DL, Dupont WD, Rogers LW, et al., Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49: 751-8.
26. Page DL, Dupont WD, Rogers LW, et al., Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197-200.
27. Phillips AJ., A comparison of treated and untreated cases of cancer of the breast. Br J Cancer 1959; 13: 20-5.
28. Roder DM, de Silva P, Zorbas HN, et al., Adherence to recommended treatments for early invasive breast cancer: decisions of women attending surgeons in the breast cancer audit of Australia and New Zealand. Asian Pac J Cancer Prev 2012; 13: 1675-82.
29. Verkooijen HM, Fioretta GM, Rapiti E, et al., Patients' refusal of surgery strongly impairs breast cancer survival. Ann Surg 2005; 242: 276-80.
30. Sanders ME, Schuyler PA, Dupont WD, et al., The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005; 103: 2481-4.
31. Wade P., Untreated carcinoma of the breast. A comparison with the results of treatment of advanced breast carcinoma. Br J Radiol 1946; 19: 272-80.
32. Wyard S., The natural duration of cancer. Br Med J 1925; 1: 206-7.
33. Bloom HJ, Richardson WW., Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-77.
34. Alpers CE, Wellings SR., The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 1985; 16: 796-807.
35. Bartow SA, Pathak DR, Black WC, et al., Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987; 60: 2751-60.
36. Bhathal PS, Brown RW, Lesueur GC, et al., Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer 1985; 51: 271-8.
37. Giarelli L, Stanta G, Delendi M, et al., Prevalence of female breast cancer observed in 517 unselected necropsies. Lancet 1986; 2: 864
38. Imaida K, Hasegawa R, Kato T, et al., Clinicopathological analysis on cancers of autopsy cases in a geriatric hospital. Pathol Int 1997; 47: 293-300.
39. Kramer WM, Rush BF, Jr., Mammary duct proliferation in the elderly. A histopathologic study. Cancer 1973; 31: 130-7.
40. Nielsen M, Jensen J, Andersen J., Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer 1984; 54: 612-5.
41. Nielsen M, Thomsen JL, Primdahl S, et al., Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987; 56: 814-9.
42. Bezic J., DCIS with foreign body giant cells as a sign of 'healing' phenomenon-a case report. Histopathology 2008; 52: 240-1.
43. Dussan C, Zubor P, Fernandez M, et al., Spontaneous regression of a breast carcinoma: a case report. Gynecol Obstet Invest 2008; 65: 206-11.
44. Horii R, Akiyama F, Kasumi F, et al., Spontaneous "healing" of breast cancer. Breast Cancer 2005; 12: 140-4.
45. Maillet L, Chopin N, Treilleux I, et al., Spontaneous regression of breast cancer after biopsy. About two cases: Regression spontanee de cancers mammaires apres biopsie: a propos de deux cas. Gynecol Obstet Fertil 2014; 42: 269-72.
46. Zahl PH, Maehlen J, Welch HG., The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008; 168: 2311-6.
47. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. Accessed on 12 December 2015.
48. Lynge E, Ponti A, James T, et al., Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer 2014; 50: 185-92.
49. Kalager M, Bretthauer M., Spontaneous regression of invasive breast cancer: does this study answer the question? Arch Intern Med 2009; 169: 997
50. Richards C., Spontaneous regression of breast cancer. Arch Intern Med 2009; 169: 996
51. Chu DZ., Unaccounted breast cancers do not infer regression of tumors. Arch Intern Med 2009; 169: 999
52. Jatoi I, Anderson WF., Breast cancer overdiagnosis with screening mammography. Arch Intern Med 2009; 169: 999-1000. author reply -1.